Study Comparing New Drug Combination with Standard Treatment for Extensive-Stage Small Cell Lung Cancer

Inclusion Criteria

• Must have a diagnosis of extensive-stage small cell lung cancer (ES-SCLC).
• Must be healthy enough to perform daily activities with little or no assistance, as measured by a specific health scale (ECOG performance scale).
• Must have at least one tumor that can be measured using imaging techniques like a CT scan or MRI, located outside the brain and nervous system.

Exclusion Criteria

• Have already received certain treatments for extensive-stage small cell lung cancer.
• Have certain health conditions, such as cancer spread to the brain causing symptoms, specific lung or heart diseases, infections, autoimmune diseases, other cancers, or nerve damage known as peripheral sensory neuropathy.
• Other specific criteria may apply.